Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11339160
Imidazole and triazole containing bicyclic compounds as JAK inhibitors
granted -
US 11339156
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
granted -
US 11339141
Methods and compounds for restoring mutant p53 function
granted -
US 11339169
P2X3 and/or P2X2/3 compounds and methods
granted -
US 11338041
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 11338037
Ultrastable antibody ionic liquids
granted -
US 11338033
Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
granted -
US 11339112
Compositions and methods comprising resveratrol
granted -
US 11338119
Implantable drug delivery devices for localized drug delivery
granted -
US 11338029
Cancer vaccines targeting PRAME and uses thereof
granted -
US 11338028
Cancer vaccines targeting LEMD1 and uses thereof
granted -
US 11338026
Identification of immunologically protective neo-epitopes for the treatment of cancers
granted -
US 11338013
Combination therapy for C3 inhibition
granted -
US 11338003
Methods of treating bladder cancer with an oncolytic virus
granted -
US 11337968
Phenylquinoline compositions for treatment of ocular disorders and conditions
granted -
US 11337971
Dopamine D3 receptor selective antagonists/partial agonists and uses thereof
granted -
US 11337969
Methods for treating cancer
granted -
US 11340237
Metabolite biomarkers for diseases associated with the contact activation system
granted -
US 11337957
Compositions comprising urolithin compounds
granted -
US 11339213
Methods and compositions for treatment of cancer
granted -
US 11339387
Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide
granted -
US 11339393
Compositions for modulating C9ORF72 expression
granted -
US 11331385
Methods of preparing anti-human papillomavirus antigen T cells
granted -
US 11332761
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.